Grifols S.A. ADR Stock
Grifols S.A. ADR Stock
A very strong showing by Grifols S.A. ADR today, with an increase of €0.30 (4.620%) compared to yesterday's price.
Pros and Cons of Grifols S.A. ADR in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Grifols S.A. ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Grifols S.A. ADR | 4.620% | 0.000% | -9.333% | 6.250% | -10.526% | 4.615% | -52.837% |
| Eledon Pharmaceuticals Inc. | -3.850% | 2.459% | 9.649% | -14.384% | 95.313% | 11.607% | -71.264% |
| Beximco Pharmaceuticals Ltd. GDR | -21.810% | -26.214% | -26.214% | -15.179% | -15.179% | -6.404% | -61.809% |
| SELLAS Life Sciences Group Inc | -3.300% | -17.586% | -17.110% | 254.950% | 26.455% | 172.831% | -53.532% |
Comments
Grifols, S.A. (NASDAQ: GRFS) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for GRFS provided by MarketBeat
Grifols, S.A. (NASDAQ: GRFS) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for GRFS provided by MarketBeat
Grifols, S.A. (NASDAQ: GRFS) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
Show more
Ratings data for GRFS provided by MarketBeat